Does PTCY increase the risk of infections?
M Mikulska, C Bartalucci, AM Raiola, C Oltolini - Blood Reviews, 2023 - Elsevier
PTCY has been mainly used in haploidentical transplant (haploHSCT), but its use in
matched donors allowed better evaluation of infectious risk conferred separately by PTCY or …
matched donors allowed better evaluation of infectious risk conferred separately by PTCY or …
CMV infection and CMV-specific immune reconstitution following haploidentical stem cell transplantation: an update
XH Luo, Y Zhu, YT Chen, LP Shui, L Liu - Frontiers in Immunology, 2021 - frontiersin.org
Haploidentical stem cell transplantation (haploSCT) has advanced to a common procedure
for treating patients with hematological malignancies and immunodeficiency diseases …
for treating patients with hematological malignancies and immunodeficiency diseases …
Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients
Y Wang, DP Wu, QF Liu, LP Xu, KY Liu… - Journal of hematology & …, 2019 - Springer
Background Low-dose post-transplant cyclophosphamide (PTCy) in conjunction with anti-
thymocyte globulin (ATG) appears as a potentially effective graft-versus-host disease …
thymocyte globulin (ATG) appears as a potentially effective graft-versus-host disease …
Clinical “real‐world” experience with letermovir for prevention of cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients
Background Letermovir was approved in 2017 for prevention of cytomegalovirus (CMV)
infection in seropositive (R+) allogeneic hematopoietic cell transplantation (HCT) patients …
infection in seropositive (R+) allogeneic hematopoietic cell transplantation (HCT) patients …
Reduced‐dose post‐transplant cyclophosphamide plus low‐dose post‐transplant anti‐thymocyte globulin as graft‐versus‐host disease prophylaxis with fludarabine …
W Zhang, R Gui, Y Zu, B Zhang, Z Li… - British Journal of …, 2023 - Wiley Online Library
Anti‐thymocyte globulin (ATG) or post‐transplant cyclophosphamide (PTCy)‐based
regimens are widely used for graft‐versus‐host disease (GVHD) prophylaxis in …
regimens are widely used for graft‐versus‐host disease (GVHD) prophylaxis in …
[HTML][HTML] Letermovir for prevention of cytomegalovirus reactivation in haploidentical and mismatched adult donor allogeneic hematopoietic cell transplantation with post …
Cytomegalovirus (CMV) is serious viral infection in allogeneic hematopoietic cell
transplantation (allo-HCT) recipients. November 2017, the novel CMV DNA terminase …
transplantation (allo-HCT) recipients. November 2017, the novel CMV DNA terminase …
Dual T-cell depletion with ATG and PTCy for peripheral blood reduced intensity conditioning allo-HSCT results in very low rates of GVHD
MQ Salas, S Prem, EG Atenafu, A Datt Law… - Bone Marrow …, 2020 - nature.com
The efficacy of posttransplant cyclophosphamide (PTCy) and antithymocyte globulin (ATG)
in controlling GVHD has been previously reported. We aim to study the safety and efficacy of …
in controlling GVHD has been previously reported. We aim to study the safety and efficacy of …
[HTML][HTML] Impact of the addition of antithymocyte globulin to post-transplantation cyclophosphamide in haploidentical transplantation with peripheral blood compared to …
The use of haploidentical hematopoietic cell transplantation (haplo-HCT) with peripheral
blood stem cells (PBSCs) to treat acute myelogenous leukemia (AML) is increasing. We …
blood stem cells (PBSCs) to treat acute myelogenous leukemia (AML) is increasing. We …
Bone marrow versus mobilized peripheral blood stem cell graft in T-cell-replete haploidentical transplantation in acute lymphoblastic leukemia
The ideal stem cell graft source remains unknown in haploidentical haematopietic cell
transplantation (haplo-HCT) with posttransplantation cyclophosphamide (PTCy). This study …
transplantation (haplo-HCT) with posttransplantation cyclophosphamide (PTCy). This study …
Modified combination of anti-thymocyte globulin (ATG) and post-transplant cyclophosphamide (PTCy) as compared with standard ATG protocol in haploidentical …
In haploidentical peripheral blood stem cell transplantation (haplo-PBSCT), the combination
of anti-thymocyte globulin and post-transplant cyclophosphamide (ATG/PTCy) has a …
of anti-thymocyte globulin and post-transplant cyclophosphamide (ATG/PTCy) has a …